A Randomized Web-based Physical Activity Intervention among Children and Adolescents with Acute Lymphoblastic Leukemia
Sandeep Batra, MD
Primary Investigator
Overview
This randomized clinical trial studies how well web-based physical activity intervention works in improving long term health in children and adolescents with newly diagnosed acute lymphoblastic leukemia that shows a decrease in or disappearance of signs and symptoms. Regular physical activity after receiving treatment for cancer may help to maintain a healthy weight and improve energy levels and overall health.
Description
This randomized clinical trial studies how well web-based physical activity intervention works in improving long term health in children and adolescents with newly diagnosed acute lymphoblastic leukemia that shows a decrease in or disappearance of signs and symptoms. Regular physical activity after receiving treatment for cancer may help to maintain a healthy weight and improve energy levels and overall health.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Acute Lymphoblastic Leukemia
-
Age: Between 8 Years - 15 Years
-
Gender: All
Inclusion Criteria
Patient must be a newly diagnosed ALL, in first remission
Patient must have completed curative chemotherapy within past 6 months at a Childrens Oncology Group (COG) institution
At the time of consent, patient or parent/guardian reports less than 420 minutes of moderate to vigorous physical activity over the last week
Patient must have access to a smart phone with Android 4.3 or later or iOS 7.1 or later or computer (laptop/desktop) with a connection to the internet to create an account and be able to sync the Sqord device (accelerometer)
Patient and at least one parent/guardian are able to read and write English; at least 1 parent/guardian must be able to read and write English in order to assist the patient with using their Sqord account
Exclusion Criteria
Patients with previous hematopoietic stem cell transplant (HSCT)
Patients with significant concurrent disease, illness, psychiatric disorder or social issue that would compromise patient safety or compliance with protocol therapy, or interfere with consent, study participation, follow up, or interpretation of study results
Female patients who are pregnant are not eligible; women of childbearing potential require a negative pregnancy test
Female patient who is postmenarcheal has agreed to use an effective contraceptive method (including abstinence) for the duration of study participation
Connect with a study center near you
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact